{
    "organizations": [],
    "uuid": "eee37d814027fb7594a827decceb3fdf8991a980",
    "author": "cnbc.com",
    "url": "http://www.cnbc.com/2018/04/17/business-wire-vertex-to-announce-first-quarter-2018-financial-results-on-april-26.html",
    "ord_in_thread": 0,
    "title": "Vertex to Announce First Quarter 2018 Financial Results on April 26",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its first quarter 2018 financial results on Thursday, April 26, 2018 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (866) 501-1537 (U.S.) or +1 (720) 545-0001 (International).\nThe conference call will be webcast live and a link to the webcast can be accessed through Vertex's website at www.vrtx.com in the \"Investors\" section. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. An archived webcast will be available on the company's website.\nAbout Vertex\nVertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.\nFounded in 1989 in Cambridge, Mass., Vertex's headquarters is now located in Boston's Innovation District. Today, the company has research and development sites and commercial offices in the United States, Europe, Canada and Australia. Vertex is consistently recognized as one of the industry's top places to work, including being named to Science magazine's Top Employers in the life sciences ranking for eight years in a row.\nFor additional information and the latest updates from the company, please visit www.vrtx.com .\n(VRTX-WEB)\nView source version on businesswire.com : https://www.businesswire.com/news/home/20180417006546/en/\nVertex Pharmaceuticals Incorporated\nInvestors:\nMichael Partridge, 617-341-6108\nor\nEric Rojas, 617-961-7205\nor\nZach Barber, 617-341-6470\nSource: Vertex Pharmaceuticals Incorporated",
    "published": "2018-04-18T00:01:00.000+03:00",
    "crawled": "2018-04-18T02:12:18.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "boston",
        "business",
        "wire",
        "vertex",
        "pharmaceutical",
        "incorporated",
        "nasdaq",
        "vrtx",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "thursday",
        "april",
        "financial",
        "market",
        "close",
        "company",
        "host",
        "conference",
        "call",
        "webcast",
        "et",
        "access",
        "call",
        "please",
        "dial",
        "international",
        "conference",
        "call",
        "webcast",
        "live",
        "link",
        "webcast",
        "accessed",
        "vertex",
        "website",
        "investor",
        "section",
        "ensure",
        "timely",
        "connection",
        "recommended",
        "participant",
        "register",
        "least",
        "minute",
        "prior",
        "scheduled",
        "webcast",
        "archived",
        "webcast",
        "available",
        "company",
        "website",
        "vertex",
        "vertex",
        "global",
        "biotechnology",
        "company",
        "invests",
        "scientific",
        "innovation",
        "create",
        "transformative",
        "medicine",
        "people",
        "serious",
        "disease",
        "addition",
        "clinical",
        "development",
        "program",
        "cf",
        "vertex",
        "dozen",
        "ongoing",
        "research",
        "program",
        "focused",
        "underlying",
        "mechanism",
        "serious",
        "disease",
        "founded",
        "cambridge",
        "vertex",
        "headquarters",
        "located",
        "boston",
        "innovation",
        "district",
        "today",
        "company",
        "research",
        "development",
        "site",
        "commercial",
        "office",
        "united",
        "state",
        "europe",
        "canada",
        "australia",
        "vertex",
        "consistently",
        "recognized",
        "one",
        "industry",
        "top",
        "place",
        "work",
        "including",
        "named",
        "science",
        "magazine",
        "top",
        "employer",
        "life",
        "science",
        "ranking",
        "eight",
        "year",
        "row",
        "additional",
        "information",
        "latest",
        "update",
        "company",
        "please",
        "visit",
        "view",
        "source",
        "version",
        "http",
        "vertex",
        "pharmaceutical",
        "incorporated",
        "investor",
        "michael",
        "partridge",
        "eric",
        "rojas",
        "zach",
        "barber",
        "source",
        "vertex",
        "pharmaceutical",
        "incorporated"
    ]
}